The First Real-world Assessment of BBV152, a COVID-19 Vaccine Developed by Bharat Biotech ... - Latest Tweet by ANI

The first real-world assessment of BBV152, a COVID-19 vaccine developed by Bharat Biotech suggests that two vaccine doses result in 50% effectiveness against symptomatic COVID-19, according to the study published in The Lancet Infectious Diseases journal— ANI (@ANI) November 24, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)